Quantitation of Sulfacetamide, Sulfadiazine, Sulfamerazine and Sulfame Thazine in Various Cominations Dsing High-Performance Liquid Chromatography

A reverse phase high-performance liquid chromatography method for the quantitation of sulfacetamide, sulfadiazine, sulfamerazine, and sulfamethazine in various combinations has been developed. The method is simple, accurate, precise and reproducible. The percent relative standard deviations based on 6 injections were 2.1, 0.6, 1.9, and 1.6 for sulfacetamide, sulfadiazine, sulfamerazine, and sulfamethazine, respectively. The ratio of peak heights (drug/internal standard) wer closely related (r value 0.99 or better) to concentrations (± 20% of the standard solution concentrations). The results of synthetic mixtures showed quantitative recovery and method was successfully applied to commercial dosage forms (tablets and suspension). Extraction of sulfa drugs from the dosage forms required a very simple procedure.     

Surface-enhanced Raman analysis of sulfa drugs on colloidal silver dispersion

Surface-enhanced Raman spectrometry (SERS) of three sulfa drugs (sulfadiazine, sulfamerazine, and sulfamethazine) is reported. Silver colloidal dispersions prepared by simple borohydride reduction of silver nitrate are used as substrates. The capability of SERS for spectral fingerprinting of analytes with close structural properties using easily prepared substrates and relatively simple instrumentation is illustrated. By careful attention to the timing in the measurement, quantitative information can be obtained from silver colloids. Linearity was achieved up to 100 ng mL-1. Limits of detection range in the low nanograms per milliliter level.     

Stability-Indicating HPLC Method for Betaxolol HCl and Its Pharmaceutical Dosage Forms

Abstract

The present work describes a specific, stability-indicating high-performance liquid chromatographic method for determination of betaxolol HCl and its pharmaceutical dosage forms. Betaxolol HCl was chromatographed on a microbondapak C18 column utilizing a simple mixture of methanol: acetonitrile:0.1% diethylamine (pH 3.0 adjusted using orthophosphoric acid). It was detected at 222 nm. The method is accurate and precise with a percent relative standard deviation of 0.11 based on 6 readings. A number of inactive ingredients present in the dosage forms (eye drop, tablet, gel) did not interfere in the assay procedure. The recovery from synthetic mixtures was quantitative. The extraction procedure from the dosage forms is very simple. The drug appears to be very sensitive to acids (such as sulfuric acid) since 100% of the drug decomposed on boiling for 5 min.     

Quantitation of Cephalexin in Pharmaceutical Dosage Forms Using High-Performance Liquid Chromatography

Abstract

A high-performance liquid chromatography method has been developed to quantify cephalexin in pharmaceutical dosage forms, capsules, pediatric drops and suspensions. The method is accurate and precise with a percent relative standard deviation of 0.8 based on 6 readings. There is no interference from a variety of excipients present in the dosage forms. The procedure for the extraction of cephalexin from the dosage forms is very simple. The method is stability indicating since a sample decomposed using sodium hydroxide showed very little potency and new peaks in the chromatogram. In the powder form cephalexin appears to be very stable.     

Quantitation of Cefaclor in Pharmaceutical Dosage Forms Using High Performance Liquid Chromatography

Abstract

A stability-indicating high-performance liquid chromatography for the quantitation of cefaclor in pharmaceutical dosage forms has been developed. The method is accurate and precise with a percent relative standard deviation of 1.2 based on 5 readings. A number of inactive ingredients present in the capsules and suspensions did not interfere with the assay procedure. The extraction procedure from the dosage forms is very simple. The recovery from the synthetic mixtures was quantitative. The capsules which had expired 3 years ago lost only 3% of the potency. The drug appears to be very sensitive to strong acids or bases since a 5 minute boiling caused 100% degradation of drug in both the solutions.     

How to search the experimental conditions that improve a Partial Least Squares calibration model: Application to a flow system with electrochemical detection for the determination of sulfonamides in milk

This paper deals with the selection of experimental conditions and how the signals obtained in these conditions influence the fitted Partial Least Squares calibration model. The multivariate signals come from a flow analysis system with amperometric detection when determining sulfadiazine, sulfamerazine and sulfamethazine in milk.The solution (carrier plus analyte) was pumped through the system to provide a continuous supply of analyte to the cell. The detector was programmed for a scan mode operation being the multivariate signal the hydrodynamic voltammogram. To obtain an analytical signal of enough analytical quality, the Net Analyte Signal and its standard deviation have been optimised by using an experimental design. The conflicting behaviour of the two responses has been solved by estimating the Pareto-optimal front.The multivariate signals recorded in the optimal conditions found have been calibrated by Partial Least Squares regression and their figures of merit validated according to the criteria established in European Decision 2002/657/EC.In relation to the permitted limit, 100 µg l^− 1 in milk, for the total content of sulfonamides established in the Commission Regulation EC no. 281/96 the proposed method has a decision limit of 109.1 µg l^− 1 and the capability of detection is 117.9 µg l^− 1 for both probability of false non-compliance and of false compliance equal to 5%. A recovery of 86.5% ± 2.4% (n = 5) has been obtained.     

Rapid and sensitive estimation of isoniazid,pyrazinamide and rifampicin in combined dosage form by reversed-phase liquid chromatography

Abstract

A rapid and sensitive method of estimation for isoniazid, pyrazinamide and rifampicin from pharmaceutical dosage was developed. The mobile phase consisting of 80:20, methanol-tetrabutyl ammonium hydroxide (0.005N) pH 3.0 adjusted with phosphoric acid was used with an ODS -CN bonded phase column. The separation of the above drugs was accomplished within 10 min at a flow rate of 1.5 ml/min. For accurate quantitation clofazimine was used as an internal standard with UV detector set at 265 nm. No interference from a variety of excipients present in the dosage forms was observed.     

Quantitation and Stability of Verapamil Hydrochloride using High-Performance Liquid Chromatography

Abstract

A high-performance liquid chromatography method for the quantitation of verapamil hydrochloride in pharmaceutical dosage forms has been developed. The method is precise and accurate with a relative standard deviation of 0.63% based on six injections. No preliminary extraction procedure is required to assay injections and a very simple extraction procedure is needed for tablets. There is no interference from the excipients and the method appears to be stability-indicating. The optimum pH range of stability is about 3.2 to 5.6 and the phosphate buffer and ionic strength have very little effect on the stability. Verapamil hydrochloride appears to be a very stable compound since in 105 days at 50°, the aqueous solutions (0.5 mg/ml) did not decompose.     

Quantitation of Acyclovir in Pharmaceutical Dosage forms using High-Performance Liquid Chromatography

Abstract

A stability-indicating high performance liquid chromatography method for the quantitation of acyclovir in pharmaceutical dosage forms (capsules, ointment and injection) has been developed. The method is accurate and precise with a percent relative standard deviation of 1.2 based on 5 readings. The excipients present in the dosage forms did not interfere with the assay method. The recovery from the synthetic mixtures was quantitative. The samples decomposed under drastic conditions showed a new peak in the chromatogram. Acyclovir appears to be more stable in the alkaline than in the acidic solution. There appears to be a distribution/decomposition problem with the ointment sample being marketed in certain types of tubes used previously and still on the market.     

Validation of Liquid Chromatographic Method of Assay for Acetaminophen,Butalbital and Caffeine in Solid Dosage Forms

Abstract

The validation of a liquid chromatographic procedure for the determination of acetaminophen, butalbital and caffeine in solid dosage forms is described. The dosage content of tablets or capsules is diluted and chromatographed on a Radialpak Cyanopropylsilane Cartridge with a mobile phase of water-acetonitrile-1M dibutylamine phosphate (90+9+1, V/V) with detection at 215 nm. The calibration curve is linear with correlation coefficients of 0.999 for each component. Recoveries of spiked excipient blend averaged 99.5% for acetaminophen, 102.5% for butalbital and 101.0% for caffeine. The method met USP requirements for system suitability with proper resolution between two adjacent peaks. The relative standard deviation (RSD) of peak response of each component (obtained by chromatographing six replicates of standard solution) is less than 2.0% and the tailing factor of each component is not greater than 1.5. The method can be used for composite, content uniformity and dissolution assay of acetaminophen, butalbital and caffeine in tablet and capsule formulations.     

Formulation of a Foaming Vaginal Tablet and Suppository

Abstract

Formulations for a foaming, spermicidal vaginal tablet and a foaming, spermicidal suppository are presented. Some pharmaceutical characteristics peculiar to both dosage forms were measured. A simple method is suggested for the evaluation of the quantity and collapse resistance of the foam.     

Quantitation of Promethazine Hydrochloride in Pharmaceutical Dosage Forms Using High Performance Liquid Chromatography

Abstract

A stability-indicating HPLC assay method has been developed to quantify promethazine hydrochloride in pharmaceutical dosage forms, injection, oral liquids, suppositories and tablets. The method is accurate and precise with a percent relative standard deviation of 0.4 based on 6 readings. The recoveries from the synthetic mixtures were quantitative. Three new peaks in the chromatogram were detected from a decomposed sample. A number of active and inactive ingredients, colors, preservatives, flavors, antioxidants, phenylephrine and codeine present in the dosage forms did not interfere with the assay procedure.     

Particle Aggregation States and Aerosol Clogging

Abstract

The clogging tendencies of different concentrations of sulfamerazine suspensions composed of suspended particles in the dispersed, coagulated, and flocculated states were studied. The dispersed suspension system showed clogging at the 10 to 15 percent solids level, while the coagulated system clogged between 5 and 10 percent, and the flocculated system clogged between the 20 and 25 percent sulfamerazine concentration. The greater the extent of coagulation of the solid particles, the lower the concentration at which clogging occurs. In the flocculated system, the particles are loosely packed in a network-meshed structure and a cake does not form. The propellant systems used were selected for their value in this theoretical study.     

Studies on Controlled Release Formulations of Pentazocine Hydrochloride

Abstract

This work embodies studies, performed with micropellet type dosage forms of Pentazocine Hydrochloride (Pz-HCl), using single and composite matrices of Eudragit RS100 (RS) and RL100 (RL). The effects of formulation parameters on various dosage form criteria - namely drug loading, particle size distribution, release profiles etc. have been investigated. Results indicate, that the two polymers can be successfully combined to produce different changes in release kinetics, with simple modifications of coating composition and initial drug loads.     

Quantitation of Propranolol Hydrochloride in Pharmaceutical Dosage Forms by High-Performance Liquid Chromatography

Abstract

A high-performance liquid-chromatography method for the quantitation of propranolol hydrochloride in pharmaceutical dosage forms (capsules, injections and tablets) has been developed. The method can also be used for contents uniformity as required by USP-NF. There is no interference from the excipients present and from hydrochlorothiazide which is often mixed with propranolol hydrochloride. The method is accurate, reproducible and precise with a percent relative standard deviation of 0.6 based on 5 readings. A sample decomposed with sodium hydroxide treatment showed about 9% potency and 2 new peaks in the chromatogram.     

Quantitation of Ranitidine Hydrochloride in Tablets and Injections Using High-Performance Liquid Chromatography

Abstract

A stability-indicating reverse-phase high-performance liquid chromatography method without the use of a counterion has been developed to quantify ranitidine hydrochloride in pharmaceutical dosage forms. The method is accurate and precise with a percent relative standard deviation of 1.5 based on 5 injections. The extraction procedure for ranitidine from tablets is very simple and there was no interference from the excipients present. Ranitidine appears to be stable to heat on the acidic side and very susceptible to decomposition on the basic side. It lost 84.4% of potency on 20 minute boiling with sodium hydroxide with a new peak in the chromatogram. It lost 37.8% of the potency on treatment with hydrogen peroxide solution for 20 minutes at room temperature with 2 new peaks in the chromatogram.     

Quantitation of Famotidine in Pharmaceutical Dosage Forms Using High-Performance Liquid Chromatography

Abstract

A stability-indicating high-performance liquid chromatography method for the quantitation of famotidine in injections, suspensions and tablets has been developed. The method is precise and accurate with a percent relative standard deviation of 1.1–1.3 based on 5 readings. The excipients present in the dosage forms did not interfere with the assay procedure. The recovery from the synthetic mixtures was quantitative. The samples decomposed under drastic conditions showed a total of 3 new peaks in the chromatograms     

A Partially Organic Dissolution Medium for Griseofulvin Dosage Forms

Abstract

Forty percent alcohol in simulated gastric fluid was used as a dissolution medium for two griseofulvin dosage forms. Rank-order correlation of dissolution profiles with plasma levels was obtained.

The use of this partially organic dissolution medium for griseofulvin dosage forms is suggested as a convenient alternative to entirely aqueous media employed in large volumes (18 to 72 liters per dosage form).     

Quantitation of 4-(4-Chl0R0Phenyl)-2-Pyrr0Lidin0Ne in Baclofen Powder and Tablets

Abstract

A high-pressure liquid chromatography method to quantify 4-(4-chlorophenyl)-2-pyrrolidinone which is present as an impurity in baclofen powder and its dosage forms has been developed. The USP-NF method for the determination of 4-(4-chlorophenyl)-2-pyrrolidinone in powder is based on TLC and is only qualitative. The developed method was successfully used to quantify 4-(4-chlorophenyl)-2-pyrrolidinone in powder (USP-NF limit 1%) and in tablets (USP-NF limit 5%). The method is accurate and reproducible with a percent error of 4% for powder and 3% for tablets.